Skip to main content
Erschienen in: Pediatric Nephrology 2/2005

01.02.2005 | Review

Genetic polymorphisms and risk for acute renal failure in preterm neonates

verfasst von: Barna Vásárhelyi, Péter Tóth-Heyn, András Treszl, Tivadar Tulassay

Erschienen in: Pediatric Nephrology | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Acute renal failure (ARF) affects about 10% of severely ill neonates. Recent studies have shown that genetic polymorphisms of proteins that play a role in neonatal physiology may contribute to individual susceptibility to both ARF and its risk factors. Our review summarizes the data collected to date. Studies have shown that the risk of preterm neonates for ARF is directly associated with a combination of high tumor necrosis factor-α producer and low interleukin-6 producer genotypes, as well as with low heat shock protein 72 producer genotype. Premature birth is itself the most important risk factor for a number of complications, including ARF, and recent studies have also shown an association between several maternal and fetal cytokine genetic polymorphisms and increased inflammatory response in preterm neonates. These polymorphisms could also be associated with increased risk for disorders such as sepsis and necrotizing enterocolitis, which lead to renal hypoperfusion and ARF. Genetic polymorphisms of the renin-angiotensin-aldosterone system have not been shown to directly influence risk for ARF. They may, however, be associated with patent ductus arteriosus, poor postnatal adaptation, and heart failure, which are all prevalent risk factors for ARF.
Literatur
1.
Zurück zum Zitat Guignard JP, Gouyon JB, John EG (1991) Vasoactive factors in the immature kidney. Pediatr Nephrol 5:443–446 Guignard JP, Gouyon JB, John EG (1991) Vasoactive factors in the immature kidney. Pediatr Nephrol 5:443–446
2.
Zurück zum Zitat Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314–320CrossRef Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314–320CrossRef
3.
Zurück zum Zitat Tóth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227–239CrossRef Tóth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227–239CrossRef
4.
Zurück zum Zitat Tufro-McReddie A, Gomez RA (1993) Ontogeny of the renin-angiotensin system. Semin Nephrol 13:519–530 Tufro-McReddie A, Gomez RA (1993) Ontogeny of the renin-angiotensin system. Semin Nephrol 13:519–530
5.
Zurück zum Zitat Chevalier RL (1996) Developmental renal physiology of the low birth weight pre-term newborn. J Urol 156:714–719CrossRef Chevalier RL (1996) Developmental renal physiology of the low birth weight pre-term newborn. J Urol 156:714–719CrossRef
6.
Zurück zum Zitat Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810 Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810
7.
Zurück zum Zitat Prevot A, Mosig D, Guignard JP (2002) The effects of losartan on renal function in the newborn rabbit. Pediatr Res 51:728–732CrossRef Prevot A, Mosig D, Guignard JP (2002) The effects of losartan on renal function in the newborn rabbit. Pediatr Res 51:728–732CrossRef
8.
Zurück zum Zitat Guignard JP, Burgener F, Calame A (1981) Persistent anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol 2:133 Guignard JP, Burgener F, Calame A (1981) Persistent anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol 2:133
9.
Zurück zum Zitat Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810 Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810
10.
Zurück zum Zitat Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMed Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMed
11.
Zurück zum Zitat Duncan JA, Scholey JW, Miller JA (2001) Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111–116 Duncan JA, Scholey JW, Miller JA (2001) Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111–116
12.
Zurück zum Zitat Nobilis A, Kocsis I, Tóth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor gene does not influence the risk of neonatal acute renal failure. Pediatr Nephrol16:1063–1066 Nobilis A, Kocsis I, Tóth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor gene does not influence the risk of neonatal acute renal failure. Pediatr Nephrol16:1063–1066
13.
Zurück zum Zitat Bender JW, Davitt MK, Jose P (1978) Angiotensin-I-converting enzyme activity in term and premature infants. Biol Neonate 34:19–23 Bender JW, Davitt MK, Jose P (1978) Angiotensin-I-converting enzyme activity in term and premature infants. Biol Neonate 34:19–23
14.
Zurück zum Zitat Walther T, Faber R, Maul B, Schultheiss HP, Siems WE, Stepan H (2002) Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE) Prenat Diagn 22:111–113 Walther T, Faber R, Maul B, Schultheiss HP, Siems WE, Stepan H (2002) Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE) Prenat Diagn 22:111–113
15.
Zurück zum Zitat Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H (2003) Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 143:746–749CrossRef Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H (2003) Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 143:746–749CrossRef
16.
Zurück zum Zitat Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, Anthuber M (2000) Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 13:190–196 Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, Anthuber M (2000) Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 13:190–196
17.
Zurück zum Zitat Treszl A, Szabó M, Dunai G, Nobilis A, Kocsis I, Machay T, Tulassay T, Vásárhelyi B (2003) Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res 54:753–755CrossRef Treszl A, Szabó M, Dunai G, Nobilis A, Kocsis I, Machay T, Tulassay T, Vásárhelyi B (2003) Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res 54:753–755CrossRef
18.
Zurück zum Zitat Lipworth BJ, Dagg KD (1994) Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 105:1360–1364 Lipworth BJ, Dagg KD (1994) Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 105:1360–1364
19.
Zurück zum Zitat Cargill RI, Lipworth BJ (1995) The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 40:11–18 Cargill RI, Lipworth BJ (1995) The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 40:11–18
20.
Zurück zum Zitat Thijs A, Thijs LG (1998) Pathogenesis of renal failure in sepsis. Kidney Int 66: S34–S37 Thijs A, Thijs LG (1998) Pathogenesis of renal failure in sepsis. Kidney Int 66: S34–S37
21.
Zurück zum Zitat Kohan DE (1994) Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 9:73–77 Kohan DE (1994) Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 9:73–77
22.
Zurück zum Zitat Uddman E, Moller S, Adner M, Edvinsson L (1999) Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223–232CrossRef Uddman E, Moller S, Adner M, Edvinsson L (1999) Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223–232CrossRef
23.
Zurück zum Zitat Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K (2000) Effects of tumor necrosis factor-α on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 36:487–492CrossRef Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K (2000) Effects of tumor necrosis factor-α on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 36:487–492CrossRef
24.
Zurück zum Zitat Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J (2000) Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28:1854–1860CrossRef Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J (2000) Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28:1854–1860CrossRef
25.
Zurück zum Zitat Treszl A, Tóth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717CrossRef Treszl A, Tóth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717CrossRef
26.
Zurück zum Zitat Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG (2003) Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58:69–77CrossRef Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG (2003) Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58:69–77CrossRef
27.
Zurück zum Zitat Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75:683–687CrossRef Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75:683–687CrossRef
28.
Zurück zum Zitat Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ (2001) The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 45:35–40CrossRef Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ (2001) The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 45:35–40CrossRef
29.
Zurück zum Zitat Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN (2003) Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 189:915–918CrossRef Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN (2003) Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 189:915–918CrossRef
30.
Zurück zum Zitat Treszl A, Kocsis I, Szathmári M, Schuler A, Héninger E, Tulassay T, Vásárhelyi B (2003) Genetic variants of TNF-α, IL-1beta, IL-4 receptor α-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 83:241–245CrossRef Treszl A, Kocsis I, Szathmári M, Schuler A, Héninger E, Tulassay T, Vásárhelyi B (2003) Genetic variants of TNF-α, IL-1beta, IL-4 receptor α-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 83:241–245CrossRef
31.
Zurück zum Zitat Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, Whitelaw A, Montgomery H (2003) Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants? Pediatrics 112:800–803CrossRef Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, Whitelaw A, Montgomery H (2003) Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants? Pediatrics 112:800–803CrossRef
32.
Zurück zum Zitat Ahrens P, Kattner E, Kohler B, Hartel C, Seidenberg J, Segerer H, Moller J, Gopel W (2004) Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 55:652–656CrossRef Ahrens P, Kattner E, Kohler B, Hartel C, Seidenberg J, Segerer H, Moller J, Gopel W (2004) Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 55:652–656CrossRef
33.
Zurück zum Zitat Treszl A, Héninger E, Kálmán A, Schuler A, Tulassay T, Vásárhelyi B (2003) Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38:1374–1378CrossRef Treszl A, Héninger E, Kálmán A, Schuler A, Tulassay T, Vásárhelyi B (2003) Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38:1374–1378CrossRef
34.
Zurück zum Zitat Héninger E, Treszl A, Kocsis I, Dérfalvi B, Tulassay T, Vásárhelyi B (2002) Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161:410–411CrossRef Héninger E, Treszl A, Kocsis I, Dérfalvi B, Tulassay T, Vásárhelyi B (2002) Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161:410–411CrossRef
35.
Zurück zum Zitat Treszl A, Kocsis I, Szathmári M, Schuler A, Tulassay T, Vásárhelyi B (2001) Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 90:1182–1185CrossRef Treszl A, Kocsis I, Szathmári M, Schuler A, Tulassay T, Vásárhelyi B (2001) Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 90:1182–1185CrossRef
36.
Zurück zum Zitat Molitoris BA (1991) New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol 1:1263–1270 Molitoris BA (1991) New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol 1:1263–1270
37.
Zurück zum Zitat Ozer EA, Yilmaz O, Akhisaroglu M, Tuna B, Bakiler AR, Ozer E. (2002) Heat shock protein 70 expression in neonatal rats after hypoxic stress. J Matern Fetal Neonatal Med 12:112–117 Ozer EA, Yilmaz O, Akhisaroglu M, Tuna B, Bakiler AR, Ozer E. (2002) Heat shock protein 70 expression in neonatal rats after hypoxic stress. J Matern Fetal Neonatal Med 12:112–117
38.
Zurück zum Zitat Vicencio A, Bidmon B, Ryu J, Reidy K,·Thulin G, Mann A, Gaudio KM, Kashgarian M, Siegel NJ (2003) Developmental expression of HSP-72 and ischemic tolerance of the immature kidney. Pediatr Nephrol 18:85–91 Vicencio A, Bidmon B, Ryu J, Reidy K,·Thulin G, Mann A, Gaudio KM, Kashgarian M, Siegel NJ (2003) Developmental expression of HSP-72 and ischemic tolerance of the immature kidney. Pediatr Nephrol 18:85–91
39.
Zurück zum Zitat Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70–2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38:491–495PubMed Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70–2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38:491–495PubMed
40.
Zurück zum Zitat Fekete A, Treszl A, Tóth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 54:452–455CrossRef Fekete A, Treszl A, Tóth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 54:452–455CrossRef
Metadaten
Titel
Genetic polymorphisms and risk for acute renal failure in preterm neonates
verfasst von
Barna Vásárhelyi
Péter Tóth-Heyn
András Treszl
Tivadar Tulassay
Publikationsdatum
01.02.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 2/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1711-x

Weitere Artikel der Ausgabe 2/2005

Pediatric Nephrology 2/2005 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.